A randomized controlled trial comparing remote blood pressure monitoring with office-based blood pressure monitoring for women at high risk of preeclampsia.

In 30 seconds

This multicenter randomized controlled trial evaluated remote blood pressure monitoring versus office-based monitoring in 270 pregnant women at high risk for preeclampsia. The primary outcome, a composite of adverse perinatal events, showed no significant difference (hazard ratio, 1.0; P=.99). However, remote monitoring reduced total antenatal visits and hospital admissions without increasing adverse outcomes.

Key findings

• No difference in primary adverse perinatal outcomes (hazard ratio, 1.0; P=.99).
• Remote monitoring reduced total antenatal attendances (14 vs 16; P<.01).
• Lower likelihood of hospital admissions for any cause in the remote group (hazard ratio, 0.54; P=.04).
• Increased antihypertensive prescriptions filled in the remote monitoring group (5 vs 3; P<.01).

Why it matters

This study suggests that remote blood pressure monitoring can effectively replace traditional office visits for high-risk pregnant women, potentially improving healthcare efficiency without compromising maternal and fetal safety.